Search research articles
Contact Us
Filters
Showing results (151-160 of 185) with videos related to
Page
of 19
Sort By:
Circulation
|
March 22, 2022
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial
Ratika Parkash, George A Wells, Jean Rouleau, et al.
American Heart Journal
|
February 27, 2022
Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationale
Girish M Nair, David H Birnie, George A Wells, et al.
American Heart Journal
|
November 7, 2018
Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate Subjects
Blandine Mondésert, Jamil Bashir, François Philippon, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|
June 23, 2022
Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trial
Jason G Andrade, Laurent Macle, Matthew T Bennett, et al.
Circulation. Arrhythmia and Electrophysiology
|
November 25, 2014
Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy
Vidal Essebag, Jacqueline Joza, David H Birnie, et al.
Journal of the American College of Cardiology
|
November 11, 2025
Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 Trial
Pablo B Nery, George A Wells, Anthony S L Tang, et al.
International Journal of Cardiology
|
May 7, 2019
Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial
Vidal Essebag, Ahmed AlTurki, Riccardo Proietti, et al.
The New England Journal of Medicine
|
November 7, 2022
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy
Jason G Andrade, Marc W Deyell, Laurent Macle, et al.
American Heart Journal
|
August 28, 2022
Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale
Pablo B Nery, George A Wells, Atul Verma, et al.
Circulation
|
May 26, 2010
Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee
Ratika Parkash, Eugene Crystal, Jamil Bashir, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 185) with videos related to
Sort By:
Page
of 19
Circulation
|
March 22, 2022
Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial
Ratika Parkash, George A Wells, Jean Rouleau, et al.
American Heart Journal
|
February 27, 2022
Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationale
Girish M Nair, David H Birnie, George A Wells, et al.
American Heart Journal
|
November 7, 2018
Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate Subjects
Blandine Mondésert, Jamil Bashir, François Philippon, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|
June 23, 2022
Randomized trial of conventional versus radiofrequency needle transseptal puncture for cryoballoon ablation: the CRYO-LATS trial
Jason G Andrade, Laurent Macle, Matthew T Bennett, et al.
Circulation. Arrhythmia and Electrophysiology
|
November 25, 2014
Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy
Vidal Essebag, Jacqueline Joza, David H Birnie, et al.
Journal of the American College of Cardiology
|
November 11, 2025
Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 Trial
Pablo B Nery, George A Wells, Anthony S L Tang, et al.
International Journal of Cardiology
|
May 7, 2019
Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial
Vidal Essebag, Ahmed AlTurki, Riccardo Proietti, et al.
The New England Journal of Medicine
|
November 7, 2022
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy
Jason G Andrade, Marc W Deyell, Laurent Macle, et al.
American Heart Journal
|
August 28, 2022
Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale
Pablo B Nery, George A Wells, Atul Verma, et al.
Circulation
|
May 26, 2010
Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee
Ratika Parkash, Eugene Crystal, Jamil Bashir, et al.
Page
of 19